Sabin Ventures

Sabin Ventures is the corporate venture arm of Grupo Sabin, one of Brazil’s largest diagnostic laboratory chains, headquartered in Brasilia. The vehicle invests at seed and Series A with checks generally in the $250K to $1M range, and its strategic remit is concentrated in diagnostic innovation, health IT software, and digital health, with explicit interest in AI applied to clinical and operational workflows. Because Sabin is a strategic CVC backed by a real operating business, the investment thesis prioritizes commercial relevance to Sabin’s lab network: workflow software, AI for image and pathology, patient engagement tools, and diagnostic technologies that can be piloted within Sabin’s footprint and then scaled. That orientation is a powerful asset for founders whose go-to-market depends on lab integration and a major Brazilian clinical channel. The geographic focus is Brazil, with Sabin’s footprint concentrated in Brasilia and expanded across multiple states. The right founder profile is a digital health or AI-for-diagnostics startup with a product that benefits materially from a partnership with a large lab operator, ideally with a prototype or working product that can be piloted relatively quickly. The wrong fit is a consumer health brand with no lab integration angle, or a deep-tech therapeutic; Sabin’s strategic logic is concentrated in the diagnostics value chain. The right entry path is through Sao Paulo and Brasilia healthtech operator networks, through introductions from co-investors at Vox, Norte, or specialist healthtech angels, and through Sabin’s own innovation team, which is reachable through corporate-development channels. When pitching, lead with the strategic fit to a diagnostic lab business: how your product reduces cost-per-test, increases throughput, improves accuracy, or unlocks new revenue lines for an operator like Sabin. Then connect to the broader market opportunity beyond Sabin itself, because no founder should be acquired by their CVC by accident. Caveats: as with any CVC, founders should think carefully about strategic conflicts, exclusivity terms, and the optics of having a single large operator as both a customer and an investor, particularly if the company hopes to sell to competing labs. Use Sabin Ventures when the strategic value of lab partnership outweighs the optics complications, and structure the relationship deliberately rather than accepting standard CVC terms.